Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been formally diagnosed with relapsing-remitting multiple sclerosis (a type of MS where symptoms come and go), confirmed using standard medical criteria
- You have not had an MS relapse or worsening of symptoms in the past 6 months
- You have reported problems with your arms or hands, such as reduced function, muscle weakness, stiffness, or pain related to MS
- You have been on a stable MS treatment for at least four weeks before joining, with no plans to change your treatment (you can continue your current treatment during the study)
- You are willing and able to use a specific vibration therapy device after receiving training on how to use it
- You can read, speak, and understand English well enough to follow instructions and take part in interviews
- You are able to travel to a laboratory for assessments
- You are able to give written consent to participate in the study
Who may not be able to join:
- You have significant memory or thinking difficulties that might make it hard to follow instructions (assessed using a short cognitive test)
- You have another neurological or psychiatric condition affecting your arms or hands — such as a history of stroke or severe carpal tunnel syndrome — that could affect the results or make the therapy unsafe
- You have an unstable heart condition or a serious medical illness that would make participation unsafe
- You have any known reasons why vibration therapy would not be safe for you, including pregnancy, a recent blood clot in a vein, severe bone loss (osteoporosis), frequent migraines, epilepsy, an active cancer in the treatment area, unstable heart disease, or a pacemaker without medical clearance (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongwu Wang, University of Florida
Phone: 352-273-9934
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Nine-Hole Peg Test (9HPT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.